Influence of Ubrogepant and Sumatriptan on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin

NCT05654298 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Migraine

Interventions

DRUG: Sumatriptan
DRUG: Ubrogepant

Sponsor

Universitaire Ziekenhuizen KU Leuven